16.85
前日終値:
$16.89
開ける:
$16.91
24時間の取引高:
227.18K
Relative Volume:
0.67
時価総額:
$430.47M
収益:
-
当期純損益:
$11.77M
株価収益率:
29.13
EPS:
0.5785
ネットキャッシュフロー:
$-19.23M
1週間 パフォーマンス:
+0.54%
1か月 パフォーマンス:
+1.20%
6か月 パフォーマンス:
-38.62%
1年 パフォーマンス:
+7.46%
Tourmaline Bio Inc Stock (TRML) Company Profile
TRML を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TRML
Tourmaline Bio Inc
|
16.85 | 430.47M | 0 | 11.77M | -19.23M | 0.5785 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-23 | 開始されました | Chardan Capital Markets | Buy |
2025-03-06 | 開始されました | Wedbush | Outperform |
2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
2024-11-11 | 繰り返されました | H.C. Wainwright | Buy |
2023-12-15 | 開始されました | Jefferies | Buy |
2023-12-04 | 再開されました | H.C. Wainwright | Buy |
2023-11-17 | 開始されました | Truist | Buy |
2023-10-31 | 開始されました | Guggenheim | Buy |
2023-10-25 | 開始されました | Piper Sandler | Overweight |
2022-10-20 | 開始されました | H.C. Wainwright | Buy |
2022-07-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
すべてを表示
Tourmaline Bio Inc (TRML) 最新ニュース
Chardan Capital Weighs in on Tourmaline Bio FY2025 Earnings - Defense World
Chardan Capital Begins Coverage on Tourmaline Bio (NASDAQ:TRML) - Defense World
Ready to Jump After Recent Trade: Tourmaline Bio Inc (TRML) - Sete News
An analyst sees good growth prospects for New Fortress Energy Inc (NFE) - Sete News
TRML Stock Sees Surge of Approximately 19.36% in Last Five Days - knoxdaily.com
Chardan sets $70 target on Tourmaline Bio, cites lead asset By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Tourmaline Bio stock By Investing.com - Investing.com Canada
Chardan Capital Initiates Coverage of Tourmaline Bio (TRML) with Buy Recommendation - MSN
Investing in Tourmaline Bio Inc (TRML) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
BARK Inc (BARK) did well last session? - uspostnews.com
STRL (Sterling Infrastructure Inc) has impressive results - uspostnews.com
Chardan Initiates Tourmaline Bio at Buy With $70 Price Target - marketscreener.com
Alliancebernstein L.P. Has $263,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - ADVFN
Here's Why We're Not Too Worried About Tourmaline Bio's (NASDAQ:TRML) Cash Burn Situation - Yahoo Finance
Pre-market Movers: CHRO, QURE, FOTA, LLY... - RTTNews
Vanguard Group Inc. Boosts Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Equity LifeStyle Properties, Inc. (NYSE:ELS) Position Boosted by Wellington Management Group LLP - Defense World
Wellington Management Group LLP Buys Shares of 114,300 Vodafone Group Public Limited (NASDAQ:VOD) - Defense World
Wellington Management Group LLP Buys 8,001 Shares of Altimmune, Inc. (NASDAQ:ALT) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Increased by Wellington Management Group LLP - Defense World
Wellington Management Group LLP Acquires 813 Shares of Ferrovial SE (NASDAQ:FER) - Defense World
Corebridge Financial Inc. Trims Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Corebridge Financial Inc. Has $199,000 Holdings in Red Violet, Inc. (NASDAQ:RDVT) - Defense World
KLP Kapitalforvaltning AS Invests $47,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Corebridge Financial Inc. Lowers Position in Chatham Lodging Trust (NYSE:CLDT) - Defense World
Franklin Resources Inc. Sells 5,012 Shares of Genworth Financial, Inc. (NYSE:GNW) - Defense World
7,700 Shares in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Acquired by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Has $213,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Franklin Resources Inc. Decreases Stake in Heidrick & Struggles International, Inc. (NASDAQ:HSII) - Defense World
Vanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Elme Communities (NYSE:ELME) Shares Bought by American Century Companies Inc. - Defense World
Norges Bank Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Can TRANQUILITY Data Propel Tourmaline Bio's Stock Price? - RTTNews
Truist Cuts Price Target on Tourmaline Bio to $63 From $74, Keeps Buy Rating - marketscreener.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of “Buy” by Brokerages - Defense World
Talaris Therapeutics stock hits 52-week low at $11.85 By Investing.com - Investing.com Canada
Prudential Financial Inc. Cuts Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Rovida Advisors Inc. Boosts Stake in Alphabet Inc. (NASDAQ:GOOGL) - Defense World
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data - Seeking Alpha
Should You Invest in H&R Block Inc (HRB) Now? - News Heater
Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Leading Factor Driving the Thyroid Eye Disease (TED) Market in 2025: Thyroid Disorders And Their Influence ... - WhaTech
ProfittoPath - TradingView
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Sold by AlphaQuest LLC - Defense World
Tourmaline Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, Wedbush Analyst Says - Defense World
HC Wainwright Raises Tourmaline Bio (NASDAQ:TRML) Price Target to $50.00 - Defense World
Tourmaline Bio Inc (TRML) 財務データ
収益
当期純利益
現金流量
EPS
Tourmaline Bio Inc (TRML) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Kulkarni Sandeep Chidambar | CEO |
Aug 16 '24 |
Buy |
13.79 |
5,221 |
71,998 |
5,221 |
大文字化:
|
ボリューム (24 時間):